Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alp Ozguzer"'
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 65, Iss 2, Pp 305-310 (2022)
Background/Aims: As targeted therapies are promising in the treatment of lung cancer (LC), it is important to identify the genetic variations in tumors. The present research aimed to determine the regional prevalence of alterations in ALK, ROS1, and
Externí odkaz:
https://doaj.org/article/37562cc2b99e4a648fc265e4de55e37b
Autor:
Alp Ozguzer, Alkan Bal, Nuri Erdoğan, Gökhan Köylüoğlu, Müge Nartürk, Ayfer Çolak, Burak Polat, Ahmet Arikan, Tunç Özdemir, Umit Bayol, Murat Anil
Publikováno v:
Pediatric Emergency Care. 33:e38-e42
The aim of the present study was to compare the pediatric appendicitis score (PAS), the Alvarado score (AS), white blood cell count (WBC), absolute neutrophil count (ANC), C-reactive protein (CRP) level, procalcitonin level, and ultrasound (US) data,
Publikováno v:
Istanbul Bilim University Florence Nightingale Journal of Medicine. 2:138-141
Malign melanom yalnizca bir deri kanseri turu degil, ayni zamanda genis bir klinik belirti ve bulgular yelpazesinde tanimlanmaktadir. Bu yazida, buyuk aksiller kitle ve masif assit nedeniyle dahiliye klinigine basvuran ve baslangicta hematolojik mali
Autor:
Altuğ Koç, Ülkü Küçük, Emel Ebru Pala, Umit Bayol, Ozge Kaya Ozer, Elif Usturali Keskin, Alp Ozguzer
Publikováno v:
Pathology & Oncology Research. 21:1223-1227
Triple negative breast cancer (TNBC), an agressive subtype accounts nearly 15 % of all breast carcinomas. Conventional chemotherapy is the only treatment modality thus new, effective targeted therapy methods have been investigated. Epidermal growth f
Publikováno v:
The Journal of Breast Health. 11:10-16
Objective: Human epidermal growth factor receptor 2 (HER2) oncoprotein is overexpressed in 15-25% of breast carcinomas and associated with poor outcome. Assessment of HER2 status accurately is important to select patients who will benefit from target
Publikováno v:
Annals of Case Reports. 1
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(1)
To investigate whether there is a difference in patient and tumor characteristics in cases with single receptor positive (SRP) (ER-/PR+ and ER+/PR-) breast carcinoma in comparison with the double receptor positive (DRP) (ER+/PR+) and double receptor
Publikováno v:
Pathology, research and practice. 209(9)
In contrast to breast HER2 testing, the optimal ISH method and antibody for gastric HER2 testing are unclear. The aim of this study was to find out gastric HER2 positivity rates in our institutional data, and to compare the two novel ISH methods with